The most common cancer diagnosed in men is prostate cancer, which has a five-year survival rate of 97%. As the approach to treatment has evolved with improving technologies and longer life expectancy for men with prostate cancer, Dr. Christien Kluwe, a radiation oncologist at Mays Cancer Center at UT Health San Antonio, emphasizes the need to balance disease control and quality of life for patients.
One question that Kluwe asks is whether every prostate cancer patient needs androgen deprivation therapy (ADT) such as testosterone blockers. He is exploring ways to identify those who would significantly benefit from a decrease in testosterone and treating them with ADT, while avoiding unnecessary treatments for those who may not benefit as much.
Kluwe is also studying radiation techniques like stereotactic body radiation therapy, which has revolutionized treatment for prostate cancer patients. With this precise and powerful technique, the standard eight weeks of treatment can now be completed in just five days. This precision allows for targeted treatment of cancer cells while sparing surrounding healthy tissue, using tiny pellets the size of rice grains.
Science & Medicine is a collaboration between TPR and The University of Texas Health Science Center at San Antonio that highlights how scientific advancements in San Antonio are improving healthcare globally. Copyright 2024 Texas Public Radio. To learn more, visit the Texas Public Radio website.
Astronauts aboard the International Space Station indulged in some delectable treats to mark the occasion…
Starting on Tuesday, Business Loop 70 in Columbia will be closed for up to 36…
Despite the challenges faced by airlines in today’s market, partnerships like the one between ANA…
In a thrilling Diamond League meet held in Paris on Sunday, 22-year-old Yaroslava Mahuchikh from…
At the Paris Diamond League, Laura Muir broke her previous British 1500m record with a…
Pearl Jam returned to the stage on Saturday night in Barcelona after postponing three shows…